Catherine Wood's BNTX Position Overview
Catherine Wood (via Ark Investment Management LLC) currently holds 133,333 shares of BioNTech SE (BNTX) worth $12.41 M, representing 0.08% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Catherine Wood has initiated a new position in BNTX, representing a fresh investment thesis on this company. Largest addition occurred in Q2 2026, adding 5,455 shares.
Analysis based on 13F filings available since 2013 Q2
Catherine Wood's BioNTech SE (BNTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly BioNTech SE (BNTX) Trades by Catherine Wood
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +5,455 | Add 4.27% | 133,333 | $93.05 |
| Q1 2026 | +127,878 | New Buy | 127,878 | $88.88 |
Catherine Wood's BioNTech SE Investment FAQs
Catherine Wood first purchased BioNTech SE (BNTX) in Q1 2026, acquiring 127,878 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Catherine Wood has held BioNTech SE (BNTX) for 2 quarters since Q1 2026.
Catherine Wood's largest addition to BioNTech SE (BNTX) was in Q1 2026, adding 127,878 shares worth $11.37 M.
According to the latest 13F filing for Q2 2026, Catherine Wood's firm, Ark Investment Management LLC, owns 133,333 shares of BioNTech SE (BNTX), valued at approximately $12.41 M.
As of the Q2 2026 filing, BioNTech SE (BNTX) represents approximately 0.08% of Catherine Wood's publicly disclosed stock portfolio, making it one of their key holdings.
Catherine Wood's peak holding in BioNTech SE (BNTX) was 133,333 shares, as reported at the end of Q2 2026.